1981

File — Box: 1, Folder: 15

Scope and Contents

From the Series: The Records of the Greater Philadelphia Committee for Medical-Pharmaceutical Sciences document the activities of the committee through meeting minutes and correspondence from 1969 until 1984. Researchers should note that information about its first five years, 1963 to 1968, is not present in this collection, and neither is information about its disbanding in 1988. Please the Related Materials note for links to the collections holding these materials. Researchers should also note that there are gaps in the correspondence, namely for the years 1970 and 1971; and that meeting minutes for some later years (1979 through 1984) are sparse.

This collection is divided into four series: Statements of purpose, Members lists, Meeting minutes, and Correspondence.

Series I: Statements of purpose contains photocopies of the original 1963 statement of purpose written when the committee was formed, as well as its revision in 1976.

Series II: Members lists hold mailing lists for the years 1978 to 1980 and attendance sheets, some undated, and some dating from 1971 through 1975.

Series III: Meeting minutes contains the final summary copies of minutes from the Steering Committee, and cover the years 1969 to 1984. Please note that some later years, from 1979 to 1984, are not well-represented; and that minutes from the committee’s first five years (1963 to 1968) and last four years (1984 to 1988) are not in this collection. Please the Related Materials note for links to the collections holding these materials.

Series IV: Correspondence dates from 1969, and 1972 through 1984, and makes up the bulk of the collection. The topics of the correspondence range from meeting agendas and dates of next meetings; dues reminders; speaker curriculum vitae; some financial reports; and letter regarding legislation the committee was especially interested in. Of note is the latter category; included in this series are letters to and regarding the General Assembly of Pennsylvania’s House bill no. 473 (1976), which (among other things) required pharmacies to provide a list of interchangeable drugs (i.e. generic drugs that could be substituted for patented, name-brand drugs). The committee opposed this bill.

Correspondence from the committee’s first five years (1963 to 1968) and last three years (1985 to 1988), as well as the years 1970 and 1971, are not present.